GetPortalImpactFactorByIdResp(projectId=1, id=271012385, cover=https://img.medsci.cn/images/journal/cover/2021/xZx_202109271314557110.jpg, fullname=Endocrine Metabolic & Immune Disorders-Drug Targets, abbr=ENDOCR METAB IMMUNE, pyear=暂无数据, frequence=Quarterly, articleNumbers=1095, citedSelf2015=2.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均5.67月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1871-5303, greenSci=https://www.greensci.net/search?kw=1871-5303, scijournal=https://www.scijournal.org/impact-factor-of-ENDOCR-METAB-IMMUNE.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.646, medsciHotlight=3.363, medsciHotlight5year=3.28404, citescore=0.0, hIndex=52, impactFactor=1.9, orgnization=Bentham Science Publishers B.V., orgnizationUrl=null, country=United Arab Emirates, countryCn=阿联酋, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=https://benthamscience.com/journal/index.php?journalID=emiddt, websiteHits=4861, guideForAuthor=null, guideForAuthorHits=4, submitWebsite=https://bsp-cms.eurekaselect.com/index.php/CDTIEMD, submitWebsiteHits=1274, content=null, totalCites=2081, brief=ENDOCR METAB IMMUNE杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=内分泌学与代谢" >内分泌学与代谢</a></strong>”子行业的级别不明杂志, articleType=该刊全部是论著，可能不接收综述类等文章, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=271012385'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=943, tagName=内分泌, createdHits=2)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.74), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.1), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.96), GetImpactFactorCiteScoreListResponse(year=2019, citescore=2.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.559), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.447), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=3.279), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=4.182), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.646)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Endocrinology, Diabetes and Metabolism , rank=114/211), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Immunology and Allergy , rank=112/188)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5303[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS[ta], article_number=140, article_number_cn=22, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)